Pattern Recognition Receptors: Significance of Expression in the Liver

被引:0
作者
Jan Żeromski
Agata Kierepa
Bartosz Brzezicha
Arleta Kowala-Piaskowska
Iwona Mozer-Lisewska
机构
[1] Karol Marcinkowski University of Medical Sciences,Chair of Pathomorphology and Clinical Immunology
[2] Karol Marcinkowski University of Medical Sciences,Chair and Department of Infectious Diseases, Hepatology and Acquired Immunodeficiencies
来源
Archivum Immunologiae et Therapiae Experimentalis | 2020年 / 68卷
关键词
PRRs; TLRs; Liver; Hepatitis; Hepatic fibrosis; Hepatocarcinogenesis;
D O I
暂无
中图分类号
学科分类号
摘要
Pattern recognition receptors (PRRs) are a pivotal part of the immune system. They are distributed in almost every site of higher organisms, able to recognize foreign pathogens or unwanted remnants of metabolism and mount innate immune response. Moreover, PRRs create bridging signaling to initiate adaptive immunity. The liver being the largest organ of the body, exposed to myriads of foreign substances often being immunogenic, is well equipped with PRRs. They act as sentinels of the organ, both in health and disease. In viral hepatitis C at least two of them, RIG-1 and TLR3 sense HCV, induce protective interferon production and create proinflammatory status. The hepatitis B virus is apparently invisible to PRRs, which has recently been denied. Besides, they are active in the course of infection. In liver injury and hepatic fibrogenesis Toll-like receptors (TLRs), predominantly TLR4, TLR3 and TLR9 are associated with gut microflora-related products and DNA from dying hepatocytes, lead to the activation of hepatic stellate cells. The latter initiate production of fibrillar collagens, the main agents forming hepatic fibrosis. Tumor cells of primary liver cancer also express PRRs, mainly TLRs. In concert with non-resolving liver inflammation, they are considered pivotal factors leading to carcinogenesis.
引用
收藏
相关论文
共 182 条
[1]  
Adolph TE(2018)Liver-microbiome axis in health and disease Rev Trends Immunol 39 712-723
[2]  
Grander C(2006)Pathogen recognition and innate immunity Cell 124 783-801
[3]  
Moschen AR(2019)Genetic variations of NOD2 and MD2 genes in hepatitis B infection Saudi J Biol Sci 26 270-280
[4]  
Akira S(2017)Inflammasomes in liver fibrosis Semin Liver Dis 37 119-127
[5]  
Uematsu S(2010)Toll-like receptor signaling and liver fibrosis Gastroenterol Res 2010 192543-501
[6]  
Takeuchi O(2016)Evaluation of NLRC4, NLRP1 and NLRP3 as components of inflammasomes, in chronic hepatitis B virus infected patients Viral Immunol 29 496-424
[7]  
Al-Anazi MR(2007)Coordinating TLR-activated signaling pathways in cells of the immune system Immunol Cell Biol 85 420-1139
[8]  
Nazir N(2005)Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus J Exp Med 202 1131-1777
[9]  
Abdo AA(2018)TLR7 agonist increases responses of hepatitis B virus specific T cells and natural killer cells in patients with chronic hepatitis B treated with nucleos(T)ide analogues Gastroenterology 154 1764-772
[10]  
Alegre F(2019)Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis J Hepatol 71 763-181